Apoptotic Effects of Co-Treatment with a Chios Gum Mastic and Eugenol on G361 Human Melanoma Cells.
- Author:
Jae Beom JO
1
;
Sang Hun OH
;
In Ryoung KIM
;
Gyoo Cheon KIM
;
Hyun Ho KWAK
;
Bong Soo PARK
Author Information
1. Department of Oral Anatomy, School of Dentistry, Pusan National University, Korea. parkbs@pusan.ac.kr
- Publication Type:Original Article
- Keywords:
chios gum mastic;
eugenol;
apoptosis;
human melanoma cells
- MeSH:
Apoptosis;
Blotting, Western;
Caspase 3;
Caspase 7;
Caspase 9;
Cytochromes c;
Cytosol;
DNA;
DNA Fragmentation;
Electrophoresis;
Eugenol;
Gingiva;
Humans;
Melanoma;
Membrane Potential, Mitochondrial;
Proteasome Endopeptidase Complex;
Proteins;
Resins, Plant
- From:International Journal of Oral Biology
2013;38(3):101-110
- CountryRepublic of Korea
- Language:English
-
Abstract:
We investigated the synergistic apoptotic effects of co-treatments with Chios gum mastic (CGM) and eugenol on G361 human melanoma cells. An MTT assay was conducted to investigate whether this co-treatment efficiently reduces the viability of G361 cells compared with each single treatment. The induction and augmentation of apoptosis were confirmed by DNA electrophoresis, Hoechst staining, and analyses of DNA hypoploidy. Western blot analysis and immunofluorescent staining were also performed to evaluate expression and translocation of apoptosis-related proteins following CGM and eugenol co-treatment. Proteasome activity and mitochondrial membrane potential (MMP) changes were also assayed.The results indicated that the co-treatment of CGM and eugenol induces multiple pathways and processes associated with an apoptotic response in G361 cells. These include nuclear condensation, DNA fragmentation, a reduction in MMP and proteasome activity, an increase of Bax and decrease of Bcl-2, a decreased DNA content, cytochrome c release into the cytosol, the translocation of AIF and DFF40 (CAD) into the nucleus, and the activation of caspase-9, caspase-7, caspase-3, PARP and DFF45 (ICAD). In contrast, separate treatments of 40 microg/ml CGM or 300 microM eugenol for 24 hours did not induce apoptosis. Our present data thus suggest that a combination therapy of CGM and eugenol is a potential treatment strategy for human melanoma.
